Within the "MH/SUD Parity Rule Division 2 Data Collection Reporting Form" template, in the worksheet titled "Claims and Utilization Review," for medical/surgical, MH/SUD, and for each of the classifications listed in §21.2425(c) of this title (relating to Claims and Utilization Review: Reporting Classifications), an issuer must provide the following aggregate claims and utilization review data for the reporting year:(1) the number of reported claims for services or benefits that have been provided:(A) in total;(B) by out-of-network providers that were covered as in-network benefits;(C) that were approved;(D) that were administratively denied; and(E) that were adversely determined;(2) the number of utilization reviews, including:(A) preauthorization requests for:(i) children ages 0 - 12;(ii) adolescents ages 13 - 17; and(iii) adults;(B) preauthorization requests approved for:(i) children ages 0 - 12;(ii) adolescents ages 13 - 17; and(iii) adults;(C) preauthorization requests that received a peer-to-peer or physician-to-physician review for:(i) children ages 0 - 12;(ii) adolescents ages 13 - 17; and(iii) adults;(D) preauthorization requests that were subject to a fail-first or step therapy requirement;(E) preauthorization requests that were adversely determined for:(i) children ages 0 - 12;(ii) adolescents ages 13 - 17; and(iii) adults;(F) concurrent reviews for:(i) children ages 0 - 12;(ii) adolescents ages 13 - 17; and(iii) adults;(G) concurrent reviews approved for:(i) children ages 0 - 12;(ii) adolescents ages 13 - 17; and(iii) adults;(H) concurrent reviews that received a peer-to-peer or physician-to-physician review for:(i) children ages 0 - 12;(ii) adolescents ages 13 - 17; and(iii) adults;(I) concurrent reviews that were adversely determined for:(i) children ages 0 - 12;(ii) adolescents ages 13 - 17; and(iii) adults;(J) retrospective reviews for:(i) children ages 0 - 12;(ii) adolescents ages 13 - 17; and(iii) adults;(K) retrospective reviews that were approved for:(i) children ages 0 - 12;(ii) adolescents ages 13 - 17; and(iii) adults;(L) retrospective reviews that received a peer-to-peer or physician-to-physician review for:(i) children ages 0 - 12;(ii) adolescents ages 13 - 17; and(iii) adults; and(M) retrospective reviews that were adversely determined for:(i) children ages 0 - 12;(ii) adolescents ages 13 - 17; and(iii) adults;(3) the number of adverse determinations that were internally appealed that:(A) then received a peer-to-peer or physician-to-physician review on internal appeal;(B) were again adversely determined on internal appeal; and(C) were reversed on internal appeal; and(4) the number of adverse determinations independently reviewed that were:(A) upheld on independent review; and(B) reversed on independent review.